Adesh Kaul is Chief Financial Officer of Basilea Pharmaceutica AG.

In his past career he held the position of CFO & Head-Corporate Development at Spexis Ltd., Research Analyst at NZB Neue Zürcher Bank AG (Investment Management) and Research Analyst at NZB Neue Zürcher Bank AG.

Mr. Kaul received an MBA from the University of St. Gallen and a graduate degree from the University of Basel.